Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Phase I (completed) The primary objective of the Phase I portion of the study is to determine the MTD of the combination of melflufen and dexamethasone in patients with relapsed and/or relapsed-refractory multiple myeloma. Phase IIa To evaluate the objective response rate (including minimal response [MR]) to the combination of melflufen and dexamethasone and melflufen as single agent at the MTD determined in Phase I.
Critère d'inclusion
- Relapsed and/or Relapsed-Refractory Multiple Myeloma